Approach to Frontline Treatment of CLL in 2018

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Approach to Frontline Treatment of CLL in 2018

By Dana-Farber Cancer Institute FEATURING Matthew Davids

598 views

September 8, 2018

0 Comments

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale

12:47

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "Experts Discuss Key Abstracts in CLL"

Feat. S. O'Brien, C. Coombs

17:05

Cleveland Clinic Taussig Cancer Institute

Frontline CLL Learnings From Phase 3 RESONATE-2, iLLUMINATE, and E19…

Feat. A. Winter

50:34

Scripps MD Anderson Cancer Center

The Cure of Leukemias in the Next Decade: An Optimist’s View

Feat. H. Kantarjian

06:53

UC Irvine Health

Fixed-Duration Treatment in CLL: Current Considerations

Feat. E. Brem

24:33

Indy Hematology Review

Therapeutic Options in CLL in 2023: Choosing the Initial Therapy Wis…

Feat. J. Woyach

08:17

Adam Kittai

Highlights From iwCLL 2023: What's New and Practice Informing i…

08:18

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…

Feat. A. Zhou

10:06

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Results of A041702, an Alliance Phase 3 S…

Feat. J. Woyach

15:21

5th SOHO Italy Annual Conference

SOHO Italy 2023: How I Treat CLL at the MD Anderson Cancer Center

Feat. A. Ferrajoli

06:28

Insights from 2023 EHA® Annual Meeting

EHA® 2023 Insights: "Venetoclax + Obinutuzumab for Previously U…

Feat. O. Al-Sawaf

06:21

City of Hope

Cardiac Safety of Zanubrutinib vs. Other BTKis in CLL

Feat. A. Danilov

11:39

5th SOHO Italy Annual Conference

SOHO Italy 2023: Current Approach to Sequencing CLL Therapy in the R…

Feat. G. Gaidano

18:01

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "MRD-Directed Therapy in CLL - Ready for Pri…

Feat. J. Rhodes

13:16

ASH 2022 Conference Coverage

Experts Discuss Key Updates in CLL

Feat. S. O'Brien, C. Coombs

09:27

ASH 2022 Conference Coverage

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

Feat. M. McMullin

10:22

SOHO 2023 Eleventh Annual Meeting

SOHO 2023 Next Questions: CLL

Feat. N. Jain

28:43

Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2023

Scripps MD Anderson Cancer Center Updates on CLL/SLL Frontline Thera…

Feat. S. O'Brien

09:27

RWJBarnabas Health Rutgers Cancer Institute of New Jersey

Fixed Duration Treatment in CLL

Feat. J. Kra

17:21

Daniel Addison

Login

Login

Join VuMedi

Approach to Frontline Treatment of CLL in 2018

Related Content